Document:

ASSIGNMENT OF WORLDWIDE RIGHT, TITLE AND INTEREST
           WITH RESERVATION OF SECURITY INTEREST

                       I.  ASSIGNMENT

       WHEREAS BIOPHAN, LLC, a limited liability company of the
  State of New York having its principal offices located at

             150 Lucius Gordon Drive, Suite 201
               West Henrietta, New York 14586
                  United States of America

  (hereinafter referred to as "Biophan") having acquired by
  Assignment the entire right, title, and interest in certain
  Inventions comprising certain new and useful improvements in

              MRI-RESISTANT CARDIAC PACEMAKERS

  that are partly described in a Provisional Patent Application,
  the disclosure of which was filed in the United States Patent
  and Trademark Office on April 20, 2000, and accorded Application
  No. 60/198,631 with Attorney Docket No.  T31-003/T31-005, and
  that are partly described in a disclosure submitted to Elman &
  Associates and assigned Attorney Docket No. T31-010 and related
  technologies for suppressing MRI energies and radio frequency
  energy from negative effects on pacemakers and certain other
  implantable and external medical devices and diagnostic systems;

       WHEREAS, IDAHO TECHNICAL, INC., a corporation of the State
  of Nevada,  having its principal offices located at

                    6352 Almquist Avenue
                         PO Box 396
                    Murray, Idaho 83874
                  United States of America

  (hereinafter referred to as the "ITI"), is desirous of acquiring
  the entire right, title, and interest in and to said Inventions,
  and in and to any Letters Patent that may be granted therefore,
  but subject to a Security Interest in favor of Biophan;

       NOW, THEREFORE, in consideration of One Dollar ($1.00)
  and of other good and valuable considerations, receipt of
  which is hereby acknowledged by Biophan, Biophan, intending to
  be legally bound, does hereby sell, assign, and transfer to
  ITI and ITI's legal representatives its entire right, title
  and interest together with all rights of priority, in said
  Inventions, as described and/or claimed in said application
  for United States patent and said diclosure and any and all
  applications for Letters Patent, in any country or
  jurisdiction, based in whole or in part thereon, including
  subsequent regular applications under 35 U.S.C. 111(a),
  divisions, continuations and continuations-in-part thereof as
  well as all foreign counterparts and all regional and
  international applications, and all applications  containing
  disclosures in common therewith, together with all Letters
  Patent in any country or jurisdiction arising from any of the
  aforesaid applications, as well as any and all reissues and
  reexaminations thereof, the same to be held and enjoyed by
  ITI, its successors and assigns, to the full ends of the terms
  of all said Letters Patent therefor which may be granted.

  Biophan hereby authorizes and requests the Patent Office
  officials in the United States and all foreign countries or
  jurisdictions to issue any and all of said Letters Patent,
  when granted, to ITI, as the assignee of its entire right,
  title and interest in and to the same, for the sole use and
  behoof of ITI, its successors and assigns.  Biophan hereby
  authorizes ITI to make applications for and to receive Letters
  Patent for said inventions in any countries or jurisdictions
  in its own name, or in the inventors' names, at its election.

       Further, Biophan hereby agrees to communicate to ITI, or
  its representatives, any facts known to Biophan respecting
  said inventions, and testify in any legal proceeding, sign all
  lawful papers, execute all divisional, continuation,
  continuation-in-part, substitution, renewal, reissue and
  related United States and foreign applications and
  declarations relating thereto, execute all necessary claims of
  priority and assignment papers to cause any and all of said
  Letters Patent to be issued to said ITI, make all rightful
  oaths, and generally to do everything possible to aid ITI, its
  successors and assigns, to obtain and enforce protection for
  said inventions in the United States and in any and all
  foreign countries or jurisdictions.  The rights and property
  herein conveyed by Biophan are free and clear of any
  encumbrances other than the Security Interest provided for
  herein.

       Biophan hereby authorizes Gerry J. Elman, Registration
  No. 24,404 of the firm Elman & Associates, to correct errors
  in this Assignment document and to insert any further
  identification or information necessary or desirable to make
  this Assignment recordable in the United States Patent and
  Trademark Office, or elsewhere.

       If any provision of this document should be found invalid
  or unenforceable under relevant law, such provision shall be
  deemed excluded and redacted herefrom, and the validity and
  enforceability of the remaining provisions shall not be
  affected thereby.

               II. GRANT OF SECURITY INTEREST

  The Inventions assigned herein are subject to a
  Security Interest, the purpose of is to secure all
  liabilities of ITI to Biophan, direct or indirect, absolute
  or contingent, due or to become due, now existing or
  hereafter arising, and all covenants of ITI recited herein
  or otherwise contained in a separate Security Agreement or
  Transfer Agreement.

       The undersigned hereby executes, grants, and
  delivers the assignment:

  For: Biophan, LLC

                                     {L.S.}         Date___________________
  by:      Michael L. Weiner, CEO

       VERIFICATION

  State of _________________________ :
                                     ss.
  County of _______________________  :

       I, a notary public duly commissioned and qualified by
  the State of ___________, United States of America, do hereby
  certify that on the            day of_______ , 2000
  before me personally appeared __________________, to me
  personally known or duly proven to be the individual whose
  name is subscribed to the foregoing instrument, who, being
  affirmed, did acknowledge himself/herself to be the
  ________________ of BIOPHAN, LLC and that he/she, as such
  officer, being authorized to do so, executed the foregoing
  instrument for the purposes therein contained, by signing the
  name of the corporation by himself/herself as such officer.  I
  have initialed the preceding pages of this document.

                                   {Seal}
           [Notary Public]

       The undersigned, IDAHO TECHNICAL, INC., hereby accepts
  the Assignment recited hereinabove, subject to the Security
  Interest recited hereinabove and agrees to the terms and
  obligations recited hereinabove.

  For:  IDAHO TECHNICAL, INC.

                                               Date___________________
                            L.S.}

   by: Printed Name ________________________________

  Title _________________________

                        VERIFICATION

  State of ___________________________:

                                     ss.
  County of __________________________:

       I, a notary public duly commissioned and qualified by
  the State of ___________, United States of America, do hereby
  certify that on the            day of_______ , 2000
  before me personally appeared __________________, to me
  personally known or duly proven to be the individual whose
  name is subscribed to the foregoing instrument, who, being
  affirmed, did acknowledge himself/herself to be the
  ________________ of IDAHO TECHNICAL, INC.  and that he/she, as
  such officer, being authorized to do so, executed the
  foregoing instrument for the purposes therein contained, by
  signing the name of the corporation by himself/herself as such
  officer.  I have initialed the preceding pages of this
  document.

                                   {Seal}
           [Notary Public]SECURITY AGREEMENT

  This Security Agreement ("Security Agreement") is made as
  of this 1 day of December, 2000, by and between Idaho Technical,
  Inc., a Nevada Corporation ("Grantor") and Biophan, LLC, a New
  York Limited Liability Company ("Secured Party").

  WHEREAS, Grantor and Secured Party are parties to that
  certain transfer agreement, dated of even date herewith (the
  "Transfer Agreement") and an assignment also dated of even date
  herewith (the Assignment), which collectively provides for the
  grant by Grantor to Secured Party of a security interest in
  certain inventions comprising certain new and useful
  improvements in MRI-Resistant Cardiac Pacemakers that are partly
  described:

            in a Provisional Patent Application, the disclosure
            of which was filed in the United States Patent and
            Trademark Office on April 20, 2000, and accorded
            Application No. 60/198,631 with Attorney Docket No.
            T31-003/T31-005,

            that are partly described in a disclosure submitted
            to Elman & Associates and assigned Attorney Docket
            No. T31-010; and

            related technologies for suppressing MRI energies and
            radio frequency energy from negative effects on
            pacemakers and certain other implantable and external
            medical devices and diagnostic systems ( collectively
            the "Patents").

  WHEREAS, Secured Party has required, as a condition to
  executing the Assignment and under the Transfer Agreement, that
  Grantor execute and deliver to Secured Party this Security
  Agreement; and

  WHEREAS, Grantor and Secured Party desire to secure the
  performance by Grantor of all of its obligations to Secured
  Party under the Transfer Agreement (collectively, the
  "Obligations") by a pledge of the property described in Section
  1 below all in accordance with the terms and conditions of this
  Security Agreement and the Transfer Agreement.
  NOW, THEREFORE, in consideration of the premises set forth
  herein and for other good and valuable consideration, the
  receipt and sufficiency of which are hereby acknowledged,
  Grantor agrees as follows:

  1.   Security Interest. To secure the complete and timely
  satisfaction of the Obligations, Grantor hereby grants,
  conveys, and assigns to Secured Party all of Grantor's right,
  title, and interest in and to the following (collectively, the
  "Collateral"):

            1.1  Patents. The Patents and patent applications listed
            above together with:
                 1.1.1.    The inventions, improvements, claims, and
                 shop rights associated therewith.
                 1.1.2.    The reissues, divisions, continuations,
                 renewals, extensions, continuations-in-part,
                 and improvements thereof.
                 1.1.3.    All income, royalties, damages, and
                 payments now and hereafter due and/or payable
                 under and with respect thereto, including,
                 without limitation, damages and payments for
                 past or future infringements thereof.
                 1.1.4.    All rights corresponding thereto,
                 including, without limitation, the right to sue
                 and recover for past, present and future
                 infringements thereof.
                 1.1.5.    All other proceeds and products of the
                 foregoing, including, without limitation, any
                 rights pursuant to its agreements with any other
                 party relating thereto.

  2.   Scope. The assignment of the Collateral herein creates a
  first-priority mortgage and security interest having priority
  over all other security interests. Secured Party's rights to the
  Collateral will be worldwide and will not require the payment of
  any royalties or other related charges by Secured Party to
  Grantor or any other person. The Collateral includes Patents now
  owned by Grantor, those Patents currently applied for and all
  Patents hereafter applied for or filed by Grantor or hereafter
  granted or otherwise arising in Grantor's interest.

  3.   Covenants. During the Term, except as may otherwise be
  provided in the Transfer Agreement and except with the prior
  written consent of Secured Party, Grantor:
            3.1. Will not enter into any agreement inconsistent with
            Grantor's obligations under this Security Agreement.
            3.2. Will, to the extent possible, continue to use proper
            statutory notice in connection with its use of the
            Patents.
            3.3. Will use commercially reasonable efforts to discover,
            preserve and protect its intellectual property; will
            file applications for Patents with respect to such
            intellectual property when commercially reasonable to
            do so, giving due consideration to the economic and
            strategic value and opinion of counsel as to
            desirability and feasibility of such application and
            will prosecute diligently all present and future
            applications for Patents.
            3.4. Will not abandon any pending Patent application.
            3.5. Will promptly pay when due all taxes and assessments
            (including patent maintenance fees) upon the
            Collateral or for its use.
            3.6. Will preserve, maintain, and enforce against
            infringement, dilution and improper use all Patents;
            and will not, directly or indirectly, take any
            action, or fail to take any action which would impair
            the validity or enforceability of any of the Patents.
            3.7. Will not create, incur or suffer or permit to be
            created or incurred or to exist any lien or security
            interest upon or against any of the Collateral that
            is prior in right to that of Secured Party.
            3.8. Will not merge or consolidate with or into any
            entity.
            3.9. Will not change its name or conduct its business
            under any other trade name.

  4.   License.
            4.1. Patents. Secured Party hereby grants to Grantor the
            royalty-free, exclusive, nontransferable right and
            license to make, have made, use, and sell the
            inventions disclosed and claimed in the Patents
            solely for Grantor's own benefit.
            4.2. Limitations. The licenses granted under this Section
            4 will terminate at the end of the Term or sooner
            upon an Event of Default (as defined below).  Except
            with the prior written consent of Secured Party,
            Grantor will not sell, assign its interest in, or
            grant any sublicense under, any of the licenses
            granted under this Section 4.

  5.   Term. The period of effectiveness of this Security
  Agreement (the "Term") will begin on the date first written
  above and will remain in full force and effect until the
  complete satisfaction of the Obligations.

  6.   Right to Inspect. Secured Party has the right, at any
  reasonable time and from time to time, to inspect Grantor's
  premises and to examine Grantor's books, records, and operations
  which are relevant to Grantor's intellectual property generally,
  to the Patents and to the enforcement of the provisions of this
  Security Agreement.

  7.   Termination. This Security Agreement is made for collateral
  purposes only. At the end of the Term, all of Secured Party's
  right, title, and interest in and to the Collateral will
  automatically revert to Grantor. In such event, Secured Party
  will execute and deliver to Grantor all termination statements
  and other instruments which are required to terminate Secured
  Party's security interest and to vest in Grantor all right,
  title, and interest in and to the Collateral, subject to any
  prior enforcement by Secured Party of its security interest as
  provided under this Security Agreement.

  8.   Expenses. Each party will bear its own expenses of
  complying with the terms of this Security Agreement. Such
  expenses of compliance for Grantor will include, without
  limitation, the expenses of maintaining the Collateral as
  provided in Section 3. Such expenses of Compliance for Secured
  Party will include, without limitation, the expenses of
  perfecting the security interest created by this Security
  Agreement.

  9.   Events of Default. An "Event of Default" will occur under
  this Security Agreement upon the happening of any of the
  following events:
            9.1. The occurrence of an event of default under the
            Transfer Agreement.
            9.2. A default in the performance of the Obligations or
            any provision of this Security Agreement.
            9.3. The Grantor, or its Parent (Parent shall mean any
            individual or entity which owns or controls, itself
            or in conjunction with an affiliate or other entity
            under its control, by contract or otherwise, at least
            fifty percent of the outstanding shares of the
            Grantor.) commences any voluntary proceeding under
            any bankruptcy, reorganization, arrangement,
            insolvency, readjustment of debt, receivership,
            dissolution, or liquidation law or statute, of any
            jurisdiction, whether now or subsequently in effect;
            or Grantor or its Parent is adjudicated insolvent or
            bankrupt by a court of competent jurisdiction; or
            Grantor or its Parent petitions or applies for,
            acquiesces in, or consents to, the appointment of any
            receiver or trustee of Grantor or its Parent for all
            or substantially all of its property or assets; or
            the Grantor or its Parent makes an assignment for the
            benefit of its creditors; or Grantor or its Parent
            admits in writing its inability to pay its debts as
            they mature.
            9.4. There is commenced against Grantor or its Parent any
            proceeding relating to Grantor or its Parent any
            bankruptcy, reorganization, arrangement, insolvency,
            readjustment of debt, receivership, dissolution, or
            liquidation law or statute, of any jurisdiction,
            whether now or subsequently in effect, and the
            proceeding remains undismissed for a period of thirty
            (30) days or Grantor or its Parent by an act
            indicates its consent to, approval of, or
            acquiescence in, the proceeding; or a receiver or
            trustee is appointed for Grantor or its Parent for
            all or substantially all of its property or assets,
            and the receivership or trusteeship remains
            undischarged for a period of thirty (30) days; or a
            warrant of attachment, execution or similar process
            is issued against any substantial part of the
            property or assets of Grantor or its Parent, and the
            warrant or similar process is not dismissed or bonded
            within thirty (30) days after the levy.
            9.5. The Grantor's failure to account, to the Secured
            Party's satisfaction, at such time as the Secured
            Party may reasonably require, for any of the
            Collateral, or proceeds thereof.
            9.6. The institution of any suit affecting the Grantor
            deemed by the Secured Party to affect adversely its
            interest hereunder in the Collateral.

  10.  Remedies. Upon the occurrence of an Event of Default, so
  long as such Event of Default has not been waived, and after
  written notice from Secured Party to Grantor of Secured Party's
  intention to enforce its rights and claims in the Collateral,
  all of the Grantor's rights in and to the Collateral will
  automatically revert to Secured Party.  Thereafter, Secured
  Party shall be authorized and empowered (1) to take any or all
  of the Collateral as Secured Party's property (a "Taking"); (2)
  to cause any or all of the Collateral to be sold (a "Sale"); or
  (3) to bring suit and take any other action in its own name to
  enforce or otherwise protect, preserve, or realize upon the
  Collateral (a "Suit"). Grantor will, at the request of Secured
  Party, and in connection with any Taking, Sale, Suit or any
  other action taken to enforce Secured Party's rights in the
  Collateral (1) do any and all lawful acts and execute any and
  all instruments reasonably required by Secured Party; and (2)
  reimburse and indemnify Secured Party for all reasonable
  expenses incurred by Secured Party.

  11.  Power of Attorney.
       11.1 Authorization. Grantor hereby authorizes Secured
       Party to:
            11.1.1.   Make, constitute, and appoint any
            representative of Secured Party as Secured Party may
            select, in its sole discretion, as Grantor's true and
            lawful attorney-in-fact, with power to endorse
            Grantor's name on all applications, documents,
            papers, and instruments necessary or desirable for
            Secured Party to give effect to the provisions of
            this Security Agreement and the intent of the parties
            hereto.
                 11.1.2.   Take any other actions with respect to the
            Collateral, consistent with this Security Agreement,
            as Secured Party deems in the best interest of
            Secured Party.
                 11.1.3.   Following the occurrence of an Event of
            Default, grant or issue any exclusive or non-
            exclusive license under the Patents to any person.
                 11.1.4.   Following the occurrence of an Event of
            Default, subject to the terms of any existing license
            agreement, assign, pledge, convey, or otherwise
            transfer title in or dispose of the Collateral to any
            person.
            11.2 Ratification. Grantor hereby ratifies all that
            Secured Party, acting as Grantor's attorney-in-fact
            will lawfully do or cause to be done by virtue
            hereof. This power of attorney will be irrevocable
            during the Term.

  12.  Cumulative Remedies. All of Secured Party's rights and
  remedies with respect to the Collateral, whether established
  hereby or by the Transfer Agreement, or by any other agreements
  or by law, will be cumulative and may be exercised individually
  or concurrently. Secured Party will have, in addition to all
  other rights and remedies given it by the terms of this Security
  Agreement, all rights and remedies allowed by law and the rights
  and remedies of a secured party under the Uniform Commercial
  Code as enacted in any jurisdiction in which the Collateral may
  be used or rights thereto enforced. Grantor acknowledges and
  agrees that this Security Agreement is not intended to limit or
  restrict in any way the rights and remedies of Secured Party
  under the Transfer Agreement but rather is intended to
  facilitate the exercise of such rights and remedies.

  13.  Waivers. No course of dealing between Grantor and Secured
  Party and no failure or delay of Secured Party to exercise any
  right, power or privilege hereunder will operate as a waiver
  thereof. No single or partial exercise of any right, power or
  privilege hereunder will preclude any other or further exercise
  thereof or the exercise of any other right, power or privilege.

  14.  Severability. The provisions of this Security Agreement are
  severable, and if any clause or provision is held invalid or
  unenforceable in whole or in part in any jurisdiction, then such
  invalidity or unenforceability will affect only such clause or
  provision, or part thereof, in such jurisdiction, and will not
  in any manner affect such clause or provision in any other
  jurisdiction, or any other clause or provision of this Security
  Agreement.

  15.  General. This Security Agreement will inure to the benefit
  of and be binding upon Grantor, Secured Party and their
  respective successors and assigns.  Grantor may not assign its
  rights or obligations under this Security Agreement without the
  prior written consent of Biophan.  No party is liable for its
  breach if such breach is due to an event beyond its reasonable
  control. All required notices must be in writing. No failure or
  delay to enforce a provision will be deemed a waiver thereof.
  This Security Agreement is governed by the internal laws of New
  York and the parties hereby consent to the jurisdiction of the
  state and federal courts located in Monroe County, New York.
  This Security Agreement along with the Assignment and Transfer
  Agreement are the entire and exclusive set of terms and
  conditions for the assignment and disposition of the Collateral
  and may only be modified by a writing signed by all parties.

  IN WITNESS WHEREOF, the parties have executed this Security
  Agreement by their signature or the signature of their duly
  authorized representatives below.

  IDAHO TECHNICAL, INC.
  By ______________________________________________
            ______________________, President

  BIOPHAN, LLC

  By ______________________________________________
           Michael L. Weiner, CEO

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00018-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00018-of-00352.parquet"}]]